FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3201004818> ?p ?o ?g. }

• W3201004818 endingPage "175346662110425" @default.
• W3201004818 startingPage "175346662110425" @default.
• W3201004818 abstract "The antifibrotic drugs nintedanib and pirfenidone are used for the treatment of idiopathic pulmonary fibrosis (IPF). We analysed the association of common profibrotic polymorphisms in MUC5B (mucin 5B, rs35705950) and DSP (desmoplakin, rs2076295) on antifibrotic treatment outcomes in IPF.MUC5B rs35705950 and DSP rs2076295 were assessed in IPF patients (n = 210, 139 men/71 women) from the Czech EMPIRE registry and age- or sex-matched healthy individuals (n = 205, 125 men/80 women). Genetic data were collated with overall survival (OS), acute exacerbation episodes, worsening lung function and antifibrotic treatment.We confirmed overexpression of the MUC5B rs35705950*T allele (55.2% versus 20.9%, p < 0.001) and the DSP rs2076295*G allele (80.4% versus 68.3%, p < 0.001) in IPF compared with controls. On antifibrotic drugs, lower mortability was observed in IPF patients with DSP G* allele (p = 0.016) and MUC5B T* allele (p = 0.079). Carriers of the DSP rs2076295*G allele benefitted from nintedanib treatment compared with TT genotype by a longer OS [hazard ratio (HR) = 7.99; 95% confidence interval (CI) = 1.56-40.90; p = 0.013] and a slower decline in lung function (HR = 8.51; 95% CI = 1.68-43.14; p = 0.010). Patients with a TT genotype (rs2076295) benefitted from treatment with pirfenidone by prolonged OS (p = 0.040; HR = 0.35; 95% CI = 0.13-0.95) compared with nintedanib treatment. Both associations were confirmed by cross-validation analysis. After stratifying by MUC5B rs35705950*T allele carriage, no difference in treatment outcome was observed for nintedanib or pirfenidone (p = 0.784). In the multivariate model, smoking, age, forced vital capacity (FVC) and DLCO (diffuse lung capacity) at the IPF diagnosis were associated with survival.Our real-world study showed that IPF patients with MUC5B T* allele or DSP G* allele profit from antifibrotic treatment by lower mortability. Moreover, carriers of the DSP rs2076295*G allele benefit from treatment with nintedanib, and TT genotype from treatment with pirfenidone. MUC5B rs35705950 did not impact the outcome of treatment with either nintedanib or pirfenidone. Our single-registry pilot study should be confirmed with an independent patient cohort." @default.
• W3201004818 created "2021-09-27" @default.
• W3201004818 creator A5004589854 @default.
• W3201004818 creator A5006406440 @default.
• W3201004818 creator A5016480427 @default.
• W3201004818 creator A5026008774 @default.
• W3201004818 creator A5035733125 @default.
• W3201004818 creator A5042672780 @default.
• W3201004818 creator A5044551311 @default.
• W3201004818 creator A5046379141 @default.
• W3201004818 creator A5061112564 @default.
• W3201004818 creator A5065414779 @default.
• W3201004818 creator A5067217947 @default.
• W3201004818 creator A5068288192 @default.
• W3201004818 creator A5075275870 @default.
• W3201004818 creator A5075786921 @default.
• W3201004818 creator A5079359036 @default.
• W3201004818 creator A5079712269 @default.
• W3201004818 creator A5084375082 @default.
• W3201004818 creator A5085241368 @default.
• W3201004818 date "2021-01-01" @default.
• W3201004818 modified "2023-10-13" @default.
• W3201004818 title "<i>DSP</i> rs2076295 variants influence nintedanib and pirfenidone outcomes in idiopathic pulmonary fibrosis: a pilot study" @default.
• W3201004818 cites W1686192005 @default.
• W3201004818 cites W1920916096 @default.
• W3201004818 cites W1938547050 @default.
• W3201004818 cites W1968123003 @default.
• W3201004818 cites W1984486655 @default.
• W3201004818 cites W1985846684 @default.
• W3201004818 cites W2031123734 @default.
• W3201004818 cites W2031644142 @default.
• W3201004818 cites W2037645843 @default.
• W3201004818 cites W2055245602 @default.
• W3201004818 cites W2069415543 @default.
• W3201004818 cites W2087442158 @default.
• W3201004818 cites W2089756110 @default.
• W3201004818 cites W2139000046 @default.
• W3201004818 cites W2154486847 @default.
• W3201004818 cites W2178655245 @default.
• W3201004818 cites W2207406313 @default.
• W3201004818 cites W2231464875 @default.
• W3201004818 cites W2253135899 @default.
• W3201004818 cites W2269533146 @default.
• W3201004818 cites W2540771245 @default.
• W3201004818 cites W2543970179 @default.
• W3201004818 cites W2579743413 @default.
• W3201004818 cites W2614365993 @default.
• W3201004818 cites W2750715393 @default.
• W3201004818 cites W2757116276 @default.
• W3201004818 cites W2767079004 @default.
• W3201004818 cites W2883693702 @default.
• W3201004818 cites W2889197569 @default.
• W3201004818 cites W2890823690 @default.
• W3201004818 cites W2917740717 @default.
• W3201004818 cites W2951968919 @default.
• W3201004818 cites W2964051463 @default.
• W3201004818 cites W2969876541 @default.
• W3201004818 cites W3010685062 @default.
• W3201004818 cites W3135081070 @default.
• W3201004818 cites W3146579488 @default.
• W3201004818 doi "https://doi.org/10.1177/17534666211042529" @default.
• W3201004818 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8442489" @default.
• W3201004818 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34515605" @default.
• W3201004818 hasPublicationYear "2021" @default.
• W3201004818 type Work @default.
• W3201004818 sameAs 3201004818 @default.
• W3201004818 citedByCount "3" @default.
• W3201004818 countsByYear W32010048182022 @default.
• W3201004818 crossrefType "journal-article" @default.
• W3201004818 hasAuthorship W3201004818A5004589854 @default.
• W3201004818 hasAuthorship W3201004818A5006406440 @default.
• W3201004818 hasAuthorship W3201004818A5016480427 @default.
• W3201004818 hasAuthorship W3201004818A5026008774 @default.
• W3201004818 hasAuthorship W3201004818A5035733125 @default.
• W3201004818 hasAuthorship W3201004818A5042672780 @default.
• W3201004818 hasAuthorship W3201004818A5044551311 @default.
• W3201004818 hasAuthorship W3201004818A5046379141 @default.
• W3201004818 hasAuthorship W3201004818A5061112564 @default.
• W3201004818 hasAuthorship W3201004818A5065414779 @default.
• W3201004818 hasAuthorship W3201004818A5067217947 @default.
• W3201004818 hasAuthorship W3201004818A5068288192 @default.
• W3201004818 hasAuthorship W3201004818A5075275870 @default.
• W3201004818 hasAuthorship W3201004818A5075786921 @default.
• W3201004818 hasAuthorship W3201004818A5079359036 @default.
• W3201004818 hasAuthorship W3201004818A5079712269 @default.
• W3201004818 hasAuthorship W3201004818A5084375082 @default.
• W3201004818 hasAuthorship W3201004818A5085241368 @default.
• W3201004818 hasBestOaLocation W32010048181 @default.
• W3201004818 hasConcept C104317684 @default.
• W3201004818 hasConcept C126322002 @default.
• W3201004818 hasConcept C135763542 @default.
• W3201004818 hasConcept C165637977 @default.
• W3201004818 hasConcept C180754005 @default.
• W3201004818 hasConcept C185592680 @default.
• W3201004818 hasConcept C207103383 @default.
• W3201004818 hasConcept C2777014857 @default.
• W3201004818 hasConcept C2777714996 @default.
• W3201004818 hasConcept C2778341716 @default.

• next